Cargando…

CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma

Background: Chondroitin sulphate synthase 3 (CHSY3) is an important enzyme that regulates glycosylation, but it has not been reported in tumours. This study explored for the first time the oncological features of CHSY3 in stomach adenocarcinoma (STAD). Methods: We analysed CHSY3 expression in STAD t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xinwei, Fan, Yongfei, Zhang, Yue, Wang, Yanyan, Zhao, Menglin, Tang, Mingyue, Li, Huiyuan, Mi, Jiaqi, Geng, Zhijun, Wang, Zishu, Su, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093181/ https://www.ncbi.nlm.nih.gov/pubmed/35571047 http://dx.doi.org/10.3389/fgene.2022.876588

Ejemplares similares

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
por: Li, Xinwei, et al.
Publicado: (2022)

Effective clinical response of lung adenocarcinoma harboring EGFR 19Del/T790M/in cis-C797S osimertinib to osimertinib and gefitinib combination therapy
por: Wang, Yanyan, et al.
Publicado: (2023)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

VEGF Mediates Tumor Growth and Metastasis by Affecting the Expression of E-Cadherin and N-Cadherin Promoting Epithelial to Mesenchymal Transition in Gastric Cancer
por: Zhang, Yue, et al.
Publicado: (2023)

The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways
por: Zhao, Menglin, et al.
Publicado: (2022)

C5aR1 shapes a non-inflammatory tumor microenvironment and mediates immune evasion in gastric cancer
por: Shen, Honghong, et al.
Publicado: (2023)

Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma
por: Chen, Junxing, et al.
Publicado: (2022)

Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis
por: Hong, Chunhong, et al.
Publicado: (2021)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
por: Han, Songling, et al.
Publicado: (2021)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma
por: Wang, Yanyan, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma
por: Luo, Lianghua, et al.
Publicado: (2022)

Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis
por: Yang, Biao, et al.
Publicado: (2020)

DNA cytosine deamination is associated with recurrent Somatic Copy Number Alterations in stomach adenocarcinoma
por: Shi, Yilin, et al.
Publicado: (2023)

Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model
por: Shen, Honghong, et al.
Publicado: (2023)

Effective treatment of MET-amplified non-small cell lung cancer patients with crizotinib: a case description
por: Tang, Mingyue, et al.
Publicado: (2023)

Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma
por: Ye, Zaisheng, et al.
Publicado: (2020)

Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance
por: Tong, Xiaoxia, et al.
Publicado: (2022)

Process evaluation of health system costing – Experience from CHSI study in India
por: Prinja, Shankar, et al.
Publicado: (2020)

CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration
por: Huang, Xinkun, et al.
Publicado: (2023)

Corrigendum: Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma
por: Ye, Zaisheng, et al.
Publicado: (2022)

Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
por: Yu, Wei, et al.
Publicado: (2022)

Sensory Nerve Maintains Intervertebral Disc Extracellular Matrix Homeostasis Via CGRP/CHSY1 Axis
por: Hu, Bo, et al.
Publicado: (2022)

An Enhancer-Based Analysis Revealed a New Function of Androgen Receptor in Tumor Cell Immune Evasion
por: Wang, Yuan, et al.
Publicado: (2020)

Establishment and Validation of a Ferroptosis-Related Long Non-Coding RNA Signature for Predicting the Prognosis of Stomach Adenocarcinoma
por: Zhang, Shuqiong, et al.
Publicado: (2022)

A Multi-Gene Model Effectively Predicts the Overall Prognosis of Stomach Adenocarcinomas With Large Genetic Heterogeneity Using Somatic Mutation Features
por: Liu, Xianming, et al.
Publicado: (2020)

CHSI costing study–Challenges and solutions for cost data collection in private hospitals in India
por: Singh, Maninder Pal, et al.
Publicado: (2022)

Data resource profile: the Korean Community Health Status Indicators (K-CHSI) database
por: Lee, Hye-Eun, et al.
Publicado: (2023)

MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis
por: Luo, Wen-Zhao, et al.
Publicado: (2023)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

High ADAMTS18 expression is associated with poor prognosis in stomach adenocarcinoma
por: Jiang, Kaiyuan, et al.
Publicado: (2020)

Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration
por: Zhang, Yetao, et al.
Publicado: (2023)

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
por: Ye, Chenyang, et al.
Publicado: (2022)

High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration
por: Wang, Jieyan, et al.
Publicado: (2023)

p53 mutation and deletion contribute to tumor immune evasion
por: Liu, Siyang, et al.
Publicado: (2023)

Identification and Validation of an Immune Evasion Molecular Subgroup of Patients With Colon Cancer for Implications of Immunotherapy
por: Zhang, Hongbin, et al.
Publicado: (2022)

Low-dose celecoxib-loaded PCL fibers reverse intervertebral disc degeneration by up-regulating CHSY3 expression
por: Wang, Yunhao, et al.
Publicado: (2023)

Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ik9jmcu8dljttot2gmp3fdg3qc